These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23510563)

  • 1. Synthesis and structure-activity relationships of carboxylic acid derivatives of pyridoxal as P2X receptor antagonists.
    Jung KY; Cho JH; Lee JS; Kim HJ; Kim YC
    Bioorg Med Chem; 2013 May; 21(9):2643-50. PubMed ID: 23510563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of potent and selective P2X₃ receptor antagonists derived from PPADS as potential pain modulators.
    Cho JH; Jung KY; Jung Y; Kim MH; Ko H; Park CS; Kim YC
    Eur J Med Chem; 2013; 70():811-30. PubMed ID: 24246730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro activity of N-benzyl-1-(2,3-dichlorophenyl)-1H-tetrazol-5-amine P2X(7) antagonists.
    Perez-Medrano A; Donnelly-Roberts DL; Florjancic AS; Nelson DW; Li T; Namovic MT; Peddi S; Faltynek CR; Jarvis MF; Carroll WA
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3297-300. PubMed ID: 21536435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.
    Kim YC; Brown SG; Harden TK; Boyer JL; Dubyak G; King BF; Burnstock G; Jacobson KA
    J Med Chem; 2001 Feb; 44(3):340-9. PubMed ID: 11462975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Potent Antiallodynic Agents for Neuropathic Pain Targeting P2X3 Receptors.
    Jung YH; Kim YO; Lin H; Cho JH; Park JH; Lee SD; Bae J; Kang KM; Kim YG; Pae AN; Ko H; Park CS; Yoon MH; Kim YC
    ACS Chem Neurosci; 2017 Jul; 8(7):1465-1478. PubMed ID: 28323403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of clinical candidate Sivopixant (S-600918): Lead optimization of dioxotriazine derivatives as selective P2X3 receptor antagonists.
    Kai H; Horiguchi T; Kameyma T; Onodera N; Itoh N; Fujii Y; Ichihashi Y; Hirai K; Shintani T; Nakamura K; Minami K; Kasai E; Yoneda S; Murakami Y; Ogawa H; Sekimoto R; Shinohara S; Yoshida O; Kurose N
    Bioorg Med Chem Lett; 2021 Nov; 52():128384. PubMed ID: 34587541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrrolinone derivatives as a new class of P2X3 receptor antagonists. Part 3: Structure-activity relationships of pyrropyrazolone derivatives.
    Tobinaga H; Kameyama T; Asahi K; Horiguchi T; Oohara M; Taoda Y; Hata K; Hasegawa T; Tada Y; Kurihara N; Kanda Y; Yagi S; Tomari M; Tanaka Y; Takahashi F; Taniguchi E; Takahara Y; Shimada S; Takeyama C; Yamamoto S; Shinohara S; Kai H
    Bioorg Med Chem Lett; 2020 Dec; 30(24):127636. PubMed ID: 33132115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery, synthesis and SAR of azinyl- and azolylbenzamides antagonists of the P2X₇ receptor.
    Subramanyam C; Duplantier AJ; Dombroski MA; Chang SP; Gabel CA; Whitney-Pickett C; Perregaux DG; Labasi JM; Yoon K; Shepard RM; Fisher M
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5475-9. PubMed ID: 21782426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship studies of pyrimidine-2,4-dione derivatives as potent P2X7 receptor antagonists.
    Park JH; Lee GE; Lee SD; Ko H; Kim YC
    Eur J Med Chem; 2015 Dec; 106():180-93. PubMed ID: 26547056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dioxotriazine derivatives as a new class of P2X
    Kai H; Horiguchi T; Kameyama T; Asahi K; Endoh T; Jikihara S; Hasegawa T; Tanaka S; Nozu A; Takeyama C; Tomari M; Takahashi F; Tamura N; Yagi S; Itoh T; Isou Y
    Bioorg Med Chem Lett; 2021 Apr; 37():127833. PubMed ID: 33540044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New P2X3 receptor antagonists. Part 2: Identification and SAR of quinazolinones.
    Szántó G; Makó A; Vágó I; Hergert T; Bata I; Farkas B; Kolok S; Vastag M
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3905-12. PubMed ID: 27426300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrrolinone derivatives as a new class of P2X3 receptor antagonists. Part 1: Initial structure-activity relationship studies of a hit from a high throughput screening.
    Tobinaga H; Kameyama T; Oohara M; Kobayashi N; Ohdan M; Ishizuka N; Kume M; Tomari M; Tanaka Y; Takahashi F; Kinoshita H; Shimada S; Shinohara S; Kai H
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2338-2342. PubMed ID: 29805055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of a Series of PPADS Analogs at P2X
    Brown SG; Kim YC; Kim SA; Jacobson KA; Burnstock G; King BF
    Drug Dev Res; 2001 Aug; 53(4):281-291. PubMed ID: 27134334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships and optimization of 3,5-dichloropyridine derivatives as novel P2X(7) receptor antagonists.
    Lee WG; Lee SD; Cho JH; Jung Y; Kim JH; Hien TT; Kang KW; Ko H; Kim YC
    J Med Chem; 2012 Apr; 55(8):3687-98. PubMed ID: 22400713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Structure-Activity Relationships of Pyridoxal-6-arylazo-5'-phosphate and Phosphonate Derivatives as P2 Receptor Antagonists.
    Kim YC; Camaioni E; Ziganshin AU; Ji XD; King BF; Wildman SS; Rychkov A; Yoburn J; Kim H; Mohanram A; Harden TK; Boyer JL; Burnstock G; Jacobson KA
    Drug Dev Res; 1998 Oct; 45(2):52-66. PubMed ID: 22922976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New P2X3 receptor antagonists. Part 1: Discovery and optimization of tricyclic compounds.
    Szántó G; Makó A; Bata I; Farkas B; Kolok S; Vastag M; Cselenyák A
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3896-904. PubMed ID: 27423478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 2.
    Brumfield S; Matasi JJ; Tulshian D; Czarniecki M; Greenlee W; Garlisi C; Qiu H; Devito K; Chen SC; Sun Y; Bertorelli R; Ansell J; Geiss W; Le VD; Martin GS; Vellekoop SA; Haber J; Allard ML
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7287-90. PubMed ID: 22078214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridoxal-5'-phosphate (MC-1), a vitamin B6 derivative, inhibits expressed P2X receptors.
    Thériault O; Poulin H; Thomas GR; Friesen AD; Al-Shaqha WA; Chahine M
    Can J Physiol Pharmacol; 2014 Mar; 92(3):189-96. PubMed ID: 24593783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamazepine derivatives with P2X4 receptor-blocking activity.
    Tian M; Abdelrahman A; Weinhausen S; Hinz S; Weyer S; Dosa S; El-Tayeb A; Müller CE
    Bioorg Med Chem; 2014 Feb; 22(3):1077-88. PubMed ID: 24411477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor.
    Baqi Y; Hausmann R; Rosefort C; Rettinger J; Schmalzing G; Müller CE
    J Med Chem; 2011 Feb; 54(3):817-30. PubMed ID: 21207957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.